Trevena (TRVN) Competitors $0.91 -0.02 (-2.28%) As of 07/17/2025 10:49 AM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOptions ChainSEC FilingsShort InterestTrendsBuy This Stock TRVN vs. ONVO, GLMD, CERO, GENE, LIPO, ENVB, SXTP, UBX, PBM, and ARAVShould you be buying Trevena stock or one of its competitors? The main competitors of Trevena include Organovo (ONVO), Galmed Pharmaceuticals (GLMD), CERo Therapeutics (CERO), Genetic Technologies (GENE), Lipella Pharmaceuticals (LIPO), Enveric Biosciences (ENVB), 60 Degrees Pharmaceuticals (SXTP), UNITY Biotechnology (UBX), Psyence Biomedical (PBM), and Aravive (ARAV). These companies are all part of the "pharmaceutical products" industry. Trevena vs. Its Competitors Organovo Galmed Pharmaceuticals CERo Therapeutics Genetic Technologies Lipella Pharmaceuticals Enveric Biosciences 60 Degrees Pharmaceuticals UNITY Biotechnology Psyence Biomedical Aravive Trevena (NASDAQ:TRVN) and Organovo (NASDAQ:ONVO) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, earnings, dividends, profitability, valuation, risk, media sentiment and analyst recommendations. Is TRVN or ONVO more profitable? Trevena has a net margin of 0.00% compared to Organovo's net margin of -10,151.64%. Trevena's return on equity of 0.00% beat Organovo's return on equity.Company Net Margins Return on Equity Return on Assets TrevenaN/A N/A -119.55% Organovo -10,151.64%-346.26%-187.53% Do analysts rate TRVN or ONVO? Trevena presently has a consensus price target of $5.00, suggesting a potential upside of 449.45%. Given Trevena's stronger consensus rating and higher possible upside, equities research analysts plainly believe Trevena is more favorable than Organovo.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Trevena 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Organovo 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the media prefer TRVN or ONVO? In the previous week, Trevena's average media sentiment score of 0.00 equaled Organovo'saverage media sentiment score. Company Overall Sentiment Trevena Neutral Organovo Neutral Do institutionals & insiders hold more shares of TRVN or ONVO? 13.6% of Trevena shares are held by institutional investors. Comparatively, 8.2% of Organovo shares are held by institutional investors. 2.7% of Trevena shares are held by insiders. Comparatively, 3.7% of Organovo shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Which has higher earnings & valuation, TRVN or ONVO? Organovo has lower revenue, but higher earnings than Trevena. Trevena is trading at a lower price-to-earnings ratio than Organovo, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTrevena$443K1.97-$40.29M-$47.04-0.02Organovo$122K0.00-$14.67M-$10.20N/A Which has more risk & volatility, TRVN or ONVO? Trevena has a beta of 0.61, indicating that its share price is 39% less volatile than the S&P 500. Comparatively, Organovo has a beta of 1.13, indicating that its share price is 13% more volatile than the S&P 500. SummaryTrevena beats Organovo on 8 of the 12 factors compared between the two stocks. Get Trevena News Delivered to You Automatically Sign up to receive the latest news and ratings for TRVN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TRVN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TRVN vs. The Competition Export to ExcelMetricTrevenaPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$873K$816.22M$5.54B$9.41BDividend YieldN/A4.84%3.75%4.03%P/E Ratio-0.021.2021.0120.09Price / Sales1.9725.49433.8199.01Price / CashN/A19.5636.1658.27Price / Book-0.086.878.125.65Net Income-$40.29M-$4.17M$3.25B$257.91M7 Day Performance-2.69%0.03%0.97%2.09%1 Month Performance-20.18%2.12%7.36%11.13%1 Year Performance-85.24%2.14%31.31%18.40% Trevena Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TRVNTrevena1.2006 of 5 stars$0.91-2.3%$5.00+449.5%-85.0%$873K$443K-0.0240Positive NewsGap DownONVOOrganovoN/AN/AN/AN/A$3.47M$122K-2.4020Gap UpGLMDGalmed Pharmaceuticals1.2597 of 5 stars$2.09+8.0%N/A-39.1%$3.45MN/A-0.1320CEROCERo Therapeutics3.9213 of 5 stars$8.67-0.6%$45.00+419.0%-97.9%$3.38MN/A0.008GENEGenetic TechnologiesN/A$0.77flatN/AN/A$3.37M$7.66M0.0050News CoverageHigh Trading VolumeLIPOLipella Pharmaceuticals1.6549 of 5 stars$0.75-9.5%N/A-79.4%$3.36M$536.36K-0.184ENVBEnveric Biosciences2.5651 of 5 stars$1.34+2.3%$10.00+646.3%-83.4%$3.31MN/A-0.0320SXTP60 Degrees Pharmaceuticals2.7385 of 5 stars$2.16-14.3%$7.00+224.1%+29.1%$3.18M$665.45K-0.043High Trading VolumeUBXUNITY Biotechnology4.5241 of 5 stars$0.18-40.4%$3.75+1,995.0%-88.1%$3.08MN/A-0.1160Positive NewsUpcoming EarningsGap DownHigh Trading VolumePBMPsyence Biomedical0.9915 of 5 stars$5.36+4.3%N/A-97.8%$3.06MN/A0.00N/APositive NewsGap UpARAVAraviveN/A$0.04flatN/AN/A$2.95M$9.14M0.0020High Trading Volume Related Companies and Tools Related Companies ONVO Alternatives GLMD Alternatives CERO Alternatives GENE Alternatives LIPO Alternatives ENVB Alternatives SXTP Alternatives UBX Alternatives PBM Alternatives ARAV Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TRVN) was last updated on 7/18/2025 by MarketBeat.com Staff From Our PartnersUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredFREE BUY ALERT: These 3 tiny AI stocks could surgeWe're living in unprecedented times. Most people think it's too late to get into AI right now … That the...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Trevena, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Trevena With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
